 | • レポートコード：GIR201107563 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、前立腺特異抗原（PSA）の世界市場を調査対象にし、前立腺特異抗原（PSA）の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（G-115、INO-5150、ADXS-PSA、AEZS-120、その他）、用途別分析（前立腺がん、転移性ホルモン不応性前立腺がん、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Advaxis, Inc.、Curevac AG、Aeterna Zentaris Inc.、OncBioMune Pharmaceuticals Inc.、Bavarian Nordic A/S、Inovio Pharmaceuticals, Inc.、GenSpera, Inc. ・メーカー別販売量、売上、市場シェア ・前立腺特異抗原（PSA）の地域別市場分析 ・前立腺特異抗原（PSA）の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・前立腺特異抗原（PSA）のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・前立腺特異抗原（PSA）のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・前立腺特異抗原（PSA）の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・前立腺特異抗原（PSA）の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・前立腺特異抗原（PSA）の種類別市場規模2015-2020：G-115、INO-5150、ADXS-PSA、AEZS-120、その他 ・前立腺特異抗原（PSA）の用途別市場規模2015-2020：前立腺がん、転移性ホルモン不応性前立腺がん、その他 ・前立腺特異抗原（PSA）の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Prostate Specific Antigen market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Prostate Specific Antigen market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Prostate Specific Antigen market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Prostate Specific Antigen market has been segmented into
G-115
INO-5150
ADXS-PSA
AEZS-120
Others
By Application, Prostate Specific Antigen has been segmented into:
Prostate Cancer
Metastatic Hormone Refractory Prostate Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prostate Specific Antigen market presented in the report. This section sheds light on the sales growth of different regional and country-level Prostate Specific Antigen markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostate Specific Antigen market.
The report offers in-depth assessment of the growth and other aspects of the Prostate Specific Antigen market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Prostate Specific Antigen Market Share Analysis
Prostate Specific Antigen competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prostate Specific Antigen sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prostate Specific Antigen sales, revenue and market share for each player covered in this report.
The major players covered in Prostate Specific Antigen are:
Advaxis, Inc.
Curevac AG
Aeterna Zentaris Inc.
OncBioMune Pharmaceuticals Inc.
Bavarian Nordic A/S
Inovio Pharmaceuticals, Inc.
GenSpera, Inc.
Among other players domestic and global, Prostate Specific Antigen market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostate Specific Antigen product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prostate Specific Antigen, with price, sales, revenue and global market share of Prostate Specific Antigen in 2018 and 2019.
Chapter 3, the Prostate Specific Antigen competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostate Specific Antigen breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Prostate Specific Antigen market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Prostate Specific Antigen sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Prostate Specific Antigen Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prostate Specific Antigen Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 G-115
1.2.3 INO-5150
1.2.4 ADXS-PSA
1.2.5 AEZS-120
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Prostate Specific Antigen Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Prostate Cancer
1.3.3 Metastatic Hormone Refractory Prostate Cancer
1.3.4 Others
1.4 Overview of Global Prostate Specific Antigen Market
1.4.1 Global Prostate Specific Antigen Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Advaxis, Inc.
2.1.1 Advaxis, Inc. Details
2.1.2 Advaxis, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Advaxis, Inc. SWOT Analysis
2.1.4 Advaxis, Inc. Product and Services
2.1.5 Advaxis, Inc. Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Curevac AG
2.2.1 Curevac AG Details
2.2.2 Curevac AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Curevac AG SWOT Analysis
2.2.4 Curevac AG Product and Services
2.2.5 Curevac AG Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Aeterna Zentaris Inc.
2.3.1 Aeterna Zentaris Inc. Details
2.3.2 Aeterna Zentaris Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Aeterna Zentaris Inc. SWOT Analysis
2.3.4 Aeterna Zentaris Inc. Product and Services
2.3.5 Aeterna Zentaris Inc. Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 OncBioMune Pharmaceuticals Inc.
2.4.1 OncBioMune Pharmaceuticals Inc. Details
2.4.2 OncBioMune Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 OncBioMune Pharmaceuticals Inc. SWOT Analysis
2.4.4 OncBioMune Pharmaceuticals Inc. Product and Services
2.4.5 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bavarian Nordic A/S
2.5.1 Bavarian Nordic A/S Details
2.5.2 Bavarian Nordic A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bavarian Nordic A/S SWOT Analysis
2.5.4 Bavarian Nordic A/S Product and Services
2.5.5 Bavarian Nordic A/S Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Inovio Pharmaceuticals, Inc.
2.6.1 Inovio Pharmaceuticals, Inc. Details
2.6.2 Inovio Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Inovio Pharmaceuticals, Inc. SWOT Analysis
2.6.4 Inovio Pharmaceuticals, Inc. Product and Services
2.6.5 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GenSpera, Inc.
2.7.1 GenSpera, Inc. Details
2.7.2 GenSpera, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GenSpera, Inc. SWOT Analysis
2.7.4 GenSpera, Inc. Product and Services
2.7.5 GenSpera, Inc. Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Prostate Specific Antigen Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Prostate Specific Antigen Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Prostate Specific Antigen Manufacturer Market Share in 2019
3.3.2 Top 6 Prostate Specific Antigen Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Prostate Specific Antigen Sales, Revenue and Market Share by Regions
4.1.1 Global Prostate Specific Antigen Sales and Market Share by Regions (2015-2020)
4.1.2 Global Prostate Specific Antigen Revenue and Market Share by Regions (2015-2020)
4.2 North America Prostate Specific Antigen Sales and Growth Rate (2015-2020)
4.3 Europe Prostate Specific Antigen Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Prostate Specific Antigen Sales and Growth Rate (2015-2020)
4.5 South America Prostate Specific Antigen Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Prostate Specific Antigen Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Prostate Specific Antigen Sales, Revenue and Market Share by Country
5.1.1 North America Prostate Specific Antigen Sales and Market Share by Country (2015-2020)
5.1.2 North America Prostate Specific Antigen Revenue and Market Share by Country (2015-2020)
5.2 United States Prostate Specific Antigen Sales and Growth Rate (2015-2020)
5.3 Canada Prostate Specific Antigen Sales and Growth Rate (2015-2020)
5.4 Mexico Prostate Specific Antigen Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Prostate Specific Antigen Sales, Revenue and Market Share by Country
6.1.1 Europe Prostate Specific Antigen Sales and Market Share by Country (2015-2020)
6.1.2 Europe Prostate Specific Antigen Revenue and Market Share by Country (2015-2020)
6.2 Germany Prostate Specific Antigen Sales and Growth Rate (2015-2020)
6.3 UK Prostate Specific Antigen Sales and Growth Rate (2015-2020)
6.4 France Prostate Specific Antigen Sales and Growth Rate (2015-2020)
6.5 Russia Prostate Specific Antigen Sales and Growth Rate (2015-2020)
6.6 Italy Prostate Specific Antigen Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Prostate Specific Antigen Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Prostate Specific Antigen Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Prostate Specific Antigen Revenue and Market Share by Regions (2015-2020)
7.2 China Prostate Specific Antigen Sales and Growth Rate (2015-2020)
7.3 Japan Prostate Specific Antigen Sales and Growth Rate (2015-2020)
7.4 Korea Prostate Specific Antigen Sales and Growth Rate (2015-2020)
7.5 India Prostate Specific Antigen Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Prostate Specific Antigen Sales and Growth Rate (2015-2020)
7.7 Australia Prostate Specific Antigen Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Prostate Specific Antigen Sales, Revenue and Market Share by Country
8.1.1 South America Prostate Specific Antigen Sales and Market Share by Country (2015-2020)
8.1.2 South America Prostate Specific Antigen Revenue and Market Share by Country (2015-2020)
8.2 Brazil Prostate Specific Antigen Sales and Growth Rate (2015-2020)
8.3 Argentina Prostate Specific Antigen Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Prostate Specific Antigen Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Prostate Specific Antigen Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Prostate Specific Antigen Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Prostate Specific Antigen Sales and Growth Rate (2015-2020)
9.3 Turkey Prostate Specific Antigen Sales and Growth Rate (2015-2020)
9.4 Egypt Prostate Specific Antigen Sales and Growth Rate (2015-2020)
9.5 South Africa Prostate Specific Antigen Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Prostate Specific Antigen Sales and Market Share by Type (2015-2020)
10.2 Global Prostate Specific Antigen Revenue and Market Share by Type (2015-2020)
10.3 Global Prostate Specific Antigen Price by Type (2015-2020)
11 Global Prostate Specific Antigen Market Segment by Application
11.1 Global Prostate Specific Antigen Sales Market Share by Application (2015-2020)
11.2 Global Prostate Specific Antigen Revenue Market Share by Application (2015-2020)
11.3 Global Prostate Specific Antigen Price by Application (2015-2020)
12 Market Forecast
12.1 Global Prostate Specific Antigen Sales, Revenue and Growth Rate (2021-2025)
12.2 Prostate Specific Antigen Market Forecast by Regions (2021-2025)
12.2.1 North America Prostate Specific Antigen Market Forecast (2021-2025)
12.2.2 Europe Prostate Specific Antigen Market Forecast (2021-2025)
12.2.3 Asia-Pacific Prostate Specific Antigen Market Forecast (2021-2025)
12.2.4 South America Prostate Specific Antigen Market Forecast (2021-2025)
12.2.5 Middle East & Africa Prostate Specific Antigen Market Forecast (2021-2025)
12.3 Prostate Specific Antigen Market Forecast by Type (2021-2025)
12.3.1 Global Prostate Specific Antigen Sales Forecast by Type (2021-2025)
12.3.2 Global Prostate Specific Antigen Market Share Forecast by Type (2021-2025)
12.4 Prostate Specific Antigen Market Forecast by Application (2021-2025)
12.4.1 Global Prostate Specific Antigen Sales Forecast by Application (2021-2025)
12.4.2 Global Prostate Specific Antigen Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Prostate Specific Antigen Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prostate Specific Antigen by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prostate Specific Antigen Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Advaxis, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Advaxis, Inc. Prostate Specific Antigen Major Business
Table 9. Advaxis, Inc. Prostate Specific Antigen Total Revenue (USD Million) (2018-2019)
Table 10. Advaxis, Inc. SWOT Analysis
Table 11. Advaxis, Inc. Prostate Specific Antigen Product and Services
Table 12. Advaxis, Inc. Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Curevac AG Basic Information, Manufacturing Base and Competitors
Table 14. Curevac AG Prostate Specific Antigen Major Business
Table 15. Curevac AG Prostate Specific Antigen Total Revenue (USD Million) (2018-2019)
Table 16. Curevac AG SWOT Analysis
Table 17. Curevac AG Prostate Specific Antigen Product and Services
Table 18. Curevac AG Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Aeterna Zentaris Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Aeterna Zentaris Inc. Prostate Specific Antigen Major Business
Table 21. Aeterna Zentaris Inc. Prostate Specific Antigen Total Revenue (USD Million) (2018-2019)
Table 22. Aeterna Zentaris Inc. SWOT Analysis
Table 23. Aeterna Zentaris Inc. Prostate Specific Antigen Product and Services
Table 24. Aeterna Zentaris Inc. Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. OncBioMune Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 26. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Major Business
Table 27. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Total Revenue (USD Million) (2018-2019)
Table 28. OncBioMune Pharmaceuticals Inc. SWOT Analysis
Table 29. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product and Services
Table 30. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Bavarian Nordic A/S Basic Information, Manufacturing Base and Competitors
Table 32. Bavarian Nordic A/S Prostate Specific Antigen Major Business
Table 33. Bavarian Nordic A/S Prostate Specific Antigen Total Revenue (USD Million) (2018-2019)
Table 34. Bavarian Nordic A/S SWOT Analysis
Table 35. Bavarian Nordic A/S Prostate Specific Antigen Product and Services
Table 36. Bavarian Nordic A/S Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Inovio Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 38. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Major Business
Table 39. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Total Revenue (USD Million) (2018-2019)
Table 40. Inovio Pharmaceuticals, Inc. SWOT Analysis
Table 41. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product and Services
Table 42. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GenSpera, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. GenSpera, Inc. Prostate Specific Antigen Major Business
Table 45. GenSpera, Inc. Prostate Specific Antigen Total Revenue (USD Million) (2018-2019)
Table 46. GenSpera, Inc. SWOT Analysis
Table 47. GenSpera, Inc. Prostate Specific Antigen Product and Services
Table 48. GenSpera, Inc. Prostate Specific Antigen Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Prostate Specific Antigen Sales by Manufacturer (2018-2019) (K Pcs)
Table 50. Global Prostate Specific Antigen Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Prostate Specific Antigen Sales by Regions (2015-2020) (K Pcs)
Table 52. Global Prostate Specific Antigen Sales Market Share by Regions (2015-2020)
Table 53. Global Prostate Specific Antigen Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Prostate Specific Antigen Sales by Countries (2015-2020) (K Pcs)
Table 55. North America Prostate Specific Antigen Sales Market Share by Countries (2015-2020)
Table 56. North America Prostate Specific Antigen Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Prostate Specific Antigen Revenue Market Share by Countries (2015-2020)
Table 58. Europe Prostate Specific Antigen Sales by Countries (2015-2020) (K Pcs)
Table 59. Europe Prostate Specific Antigen Sales Market Share by Countries (2015-2020)
Table 60. Europe Prostate Specific Antigen Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Prostate Specific Antigen Sales by Regions (2015-2020) (K Pcs)
Table 62. Asia-Pacific Prostate Specific Antigen Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Prostate Specific Antigen Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Prostate Specific Antigen Sales by Countries (2015-2020) (K Pcs)
Table 65. South America Prostate Specific Antigen Sales Market Share by Countries (2015-2020)
Table 66. South America Prostate Specific Antigen Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Prostate Specific Antigen Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Prostate Specific Antigen Sales by Countries (2015-2020) (K Pcs)
Table 69. Middle East & Africa Prostate Specific Antigen Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Prostate Specific Antigen Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Prostate Specific Antigen Revenue Market Share by Countries (2015-2020)
Table 72. Global Prostate Specific Antigen Sales by Type (2015-2020) (K Pcs)
Table 73. Global Prostate Specific Antigen Sales Share by Type (2015-2020)
Table 74. Global Prostate Specific Antigen Revenue by Type (2015-2020) (USD Million)
Table 75. Global Prostate Specific Antigen Revenue Share by Type (2015-2020)
Table 76. Global Prostate Specific Antigen Sales by Application (2015-2020) (K Pcs)
Table 77. Global Prostate Specific Antigen Sales Share by Application (2015-2020)
Table 78. Global Prostate Specific Antigen Sales Forecast by Regions (2021-2025) (K Pcs)
Table 79. Global Prostate Specific Antigen Market Share Forecast by Regions (2021-2025)
Table 80. Global Prostate Specific Antigen Sales Forecast by Type (2021-2025) (K Pcs)
Table 81. Global Prostate Specific Antigen Market Share Forecast by Type (2021-2025)
Table 82. Global Prostate Specific Antigen Sales Forecast by Application (2021-2025)
Table 83. Global Prostate Specific Antigen Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Prostate Specific Antigen Picture
Figure 2. Global Sales Market Share of Prostate Specific Antigen by Type in 2019
Figure 3. G-115 Picture
Figure 4. INO-5150 Picture
Figure 5. ADXS-PSA Picture
Figure 6. AEZS-120 Picture
Figure 7. Others Picture
Figure 8. Prostate Specific Antigen Sales Market Share by Application in 2018
Figure 9. Prostate Cancer Picture
Figure 10. Metastatic Hormone Refractory Prostate Cancer Picture
Figure 11. Others Picture
Figure 12. Global Prostate Specific Antigen Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Prostate Specific Antigen Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Prostate Specific Antigen Sales Market Share by Manufacturer in 2019
Figure 33. Global Prostate Specific Antigen Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Prostate Specific Antigen Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Prostate Specific Antigen Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Prostate Specific Antigen Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Prostate Specific Antigen Revenue Market Share by Regions (2015-2020)
Figure 40. Global Prostate Specific Antigen Revenue Market Share by Regions in 2018
Figure 41. North America Prostate Specific Antigen Sales and Growth Rate (2015-2020)
Figure 42. Europe Prostate Specific Antigen Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Prostate Specific Antigen Sales and Growth Rate (2015-2020)
Figure 44. South America Prostate Specific Antigen Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Prostate Specific Antigen Sales and Growth Rate (2015-2020)
Figure 46. North America Prostate Specific Antigen Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Prostate Specific Antigen Sales Market Share by Countries (2015-2020)
Figure 48. North America Prostate Specific Antigen Sales Market Share by Countries in 2018
Figure 49. North America Prostate Specific Antigen Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Prostate Specific Antigen Revenue Market Share by Countries in 2018
Figure 51. United States Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Prostate Specific Antigen Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Prostate Specific Antigen Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Prostate Specific Antigen Revenue Market Share by Countries in 2019
Figure 57. Germany Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Prostate Specific Antigen Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Prostate Specific Antigen Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Prostate Specific Antigen Revenue Market Share by Regions 2019
Figure 65. China Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Prostate Specific Antigen Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Prostate Specific Antigen Sales Market Share by Countries in 2019
Figure 72. South America Prostate Specific Antigen Revenue Market Share by Countries in 2019
Figure 73. Brazil Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Prostate Specific Antigen Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Prostate Specific Antigen Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Prostate Specific Antigen Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Prostate Specific Antigen Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Prostate Specific Antigen Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Prostate Specific Antigen Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Prostate Specific Antigen Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Prostate Specific Antigen Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Prostate Specific Antigen Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Prostate Specific Antigen Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Prostate Specific Antigen Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Prostate Specific Antigen Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
前立腺生検装置の世界市場 2020年 Market Overview The Prostate Biopsy Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 腫瘍バイオマーカー検査の世界市場 2020年 Market Overview The global Tumor Biomarker Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor Biomarker Test mar…
- 癌胎児性抗原関連細胞接着分子5の世界市場 2020年 Market Overview The global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million …
- T細胞抗原Gp39の世界市場 2020年 Market Overview The global T Cell Antigen Gp39 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The T Cell Antigen Gp39 marke…
- 白血球表面抗原CD47の世界市場 2020年 Market Overview The global Leukocyte Surface Antigen CD47 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Leukocyte Surf…